Abstract: A method for screening a test compound for activity in modulating the activity of the chloride channel ClC-7 either directly or by modulating the subcellular localization of Ostm1 comprises determining whether test compound inhibits the binding of Ostm1 to ClC-7. Compounds active in the screen are candidates for use in treating bone resorption conditions such as Osteoporosis by modulating the activity of osteoclasts.
Type:
Grant
Filed:
December 18, 2006
Date of Patent:
December 14, 2010
Assignee:
Pharmos Bioscience A/S
Inventors:
Philipp Lange, Jens C. Fuhrmann, Thomas Jentsch
Abstract: A method for screening a test compound for activity in modulating the activity of the chloride channel ClC-7 either directly or by modulating the subcellular localization of Ostm1 comprises determining whether test compound inhibits the binding of Ostm1 to ClC-7. Compounds active in the screen are candidates for use in treating bone resorption conditions such as Osteoporosis by modulating the activity of osteoclasts.
Type:
Application
Filed:
December 18, 2006
Publication date:
July 2, 2009
Applicant:
PHARMOS BIOSCIENCE A/S
Inventors:
Philipp Lange, Jens C. Fuhrmann, Thomas Jentsch